Correlation Between Delta 9 and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Delta 9 and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delta 9 and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delta 9 Cannabis and ANI Pharmaceuticals, you can compare the effects of market volatilities on Delta 9 and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delta 9 with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delta 9 and ANI Pharmaceuticals.
Diversification Opportunities for Delta 9 and ANI Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Delta and ANI is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Delta 9 Cannabis and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Delta 9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delta 9 Cannabis are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Delta 9 i.e., Delta 9 and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Delta 9 and ANI Pharmaceuticals
If you would invest 5,787 in ANI Pharmaceuticals on December 1, 2024 and sell it today you would earn a total of 402.00 from holding ANI Pharmaceuticals or generate 6.95% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Delta 9 Cannabis vs. ANI Pharmaceuticals
Performance |
Timeline |
Delta 9 Cannabis |
ANI Pharmaceuticals |
Delta 9 and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Delta 9 and ANI Pharmaceuticals
The main advantage of trading using opposite Delta 9 and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delta 9 position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.Delta 9 vs. Benchmark Botanics | Delta 9 vs. Speakeasy Cannabis Club | Delta 9 vs. City View Green | Delta 9 vs. BC Craft Supply |
ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
CEOs Directory Screen CEOs from public companies around the world |